inspect molecule / jeuveau
Jeuveau
Botulinum Toxin Type A o--o \/ /\ o--o
Botulinum Toxin Type A is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyBotulinum Toxin Type A
administration routeIntramuscular
price comparison status2 snapshots
safety signal rating54 / 100
Acetylcholine Release Inhibitor [EPC]openFDA NDC seedopenFDA NDC100 [USP'U]/1
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Acetylcholine Release Inhibitor [EPC].
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 691 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Falling3M: -1.8%12M: -7.3%
Jul 2025Jun 2026
Jan 2026$25.40
Feb 2026$25.20
Mar 2026$25.00
Apr 2026$24.80
May 2026$24.75
Jun 2026$24.54
01 / chemistryEvolus, Inc.
Ingredient Breakdown
active moietyBotulinum Toxin Type A
formulationIntramuscular Acetylcholine Release Inhibitor [EPC]
mechanism of action
Acetylcholine Release Inhibitor [EPC]
available strengths
100 [USP'U]/1
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
- Read the official label for route-specific directions, contraindications, and storage.
- Ask a clinician or pharmacist before substituting products across countries or formulations.
- Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same